Financials

Q3 2018

As expected revenue growth was in Q3 2018 extraordinarily impacted by the one-off settlement with a customer within IT Solution Services of DKK 33m in Q3 2017. Thus, revenue in reported currencies increased by 11% in Q3 2018 (11% in constant currencies) and 5.6% adjusted for the one-off settlement. In 9M 2018 revenue in reported currencies increased by 5.4% (5.9% in constant currencies) driven by the international life sciences, enterprise and public customer groups. The organic revenue growth (i.e. excluding SCALES) in reported currencies was 2.5% in 9M 2018 compared to 9M 2017. Operating profit margin in reported currencies was 9.0% in Q3 2018 (9.4% in constant currencies) and 9.2% in 9M 2018 (8.9% in constant currencies) compared to 4.2% in Q3 2017 and 7.9% in 9M 2017.

The order backlog for 2018 at the beginning of Q4 2018 increased by DKK 136.4m, or by 5.0%, to DKK 2,846m compared to the order backlog for 2017 at the beginning of Q4 2017. The order backlog for 2018 at the beginning of Q4 2018 does not include an order backlog for the acquired company, Valiance Partners. This acquisition is expected to generate additional revenue in the last two months of 2018 of around DKK 15 million corresponding to approximately 0.5pp growth in 2018. The guidance for 2018 revenue growth is 4-7% in constant currencies including the acquisition of Valiance Partners. The growth is based on IFRS 15 restated 2017 revenue of DKK 2,851m. The operating profit margin in constant currencies is maintained in the interval 10- 10.5% for 2018.

   

I am pleased to see continued strong revenue growth from the international life sciences, enterprise and public customer groups, all growing with more than 20% in 9M 2018. With the acquisition of the fast-growing IT-service provider to the international life sciences industry, Valiance Partners, and the solid 9M 2018 revenue development we have recently been able to increase our full year revenue guidance to 4-7% from previously 3-6%.” 

Per Kogut, Chief Executive Officer (CEO)

Investor relations contact

Klaus Hosbond Skovrup
Head of Investor Relations

Email
+45 3079 5355

Email alerts

To subscribe to receive updates by email.

Subscribe

Follow NNIT